Literature DB >> 8149672

T cell reactivity against antigen 85 but not against the 18- and 65-kD heat shock proteins in the early stages of acquired immunity against Mycobacterium leprae.

P Launois1, M Niang N'Diaye, J L Sarthou, A Drowart, J P Van Vooren, J L Cartel, K Huygen.   

Abstract

T cell proliferation and interferon-gamma (IFN-gamma) production of peripheral blood mononuclear cells (PBMC) from 20 household contacts were tested against the 18- and 65-kD heat shock proteins from Mycobacterium leprae (ML18 and ML65 respectively) and antigen 85 from Myco. bovis bacille Calmette-Guérin (BCG) (Ag 85) during a 12-months follow-up study. Among the eight contacts that became positive, eight showed positive reactivity against Ag 85, 5/8 against ML65 and 4/8 against ML18 at the end of the study. Of the 16 contacts who were lepromin-positive either at first or second testing, all responded to Ag 85, 11 to ML 65, but only eight reacted to ML18 antigen. Contacts who were lepromin-positive at first testing developed responses to ML18 only at second testing. In contrast, among the four contacts that remained lepromin-negative during the follow up, three proliferated to Ag 85 either at first or second testing, but only one produced IFN-gamma against Ag 85 at the end of the study. These results demonstrated that T cell reactivity and particularly IFN-gamma secretion against Ag 85, but not against ML18 and ML65, might be a predominant mechanism in the early stages of acquired protective immunity against Myco. leprae.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8149672      PMCID: PMC1534519          DOI: 10.1111/j.1365-2249.1994.tb06235.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  26 in total

1.  Serological response of patients with leprosy to a 28- to 30-kilodalton protein doublet from early cultures of Mycobacterium bovis BCG.

Authors:  M C Pessolani; F D Rumjanek; M A Marques; F S de Melo; E N Sarno
Journal:  J Clin Microbiol       Date:  1989-10       Impact factor: 5.948

2.  A protein antigen of Mycobacterium leprae is related to a family of small heat shock proteins.

Authors:  A H Nerland; A S Mustafa; D Sweetser; T Godal; R A Young
Journal:  J Bacteriol       Date:  1988-12       Impact factor: 3.490

3.  Immunological effects of lepromin testing in Sri Lankan population groups. I. Effect of repeated lepromin testing.

Authors:  M R Pinto; N B Eriyagama; V Pemajayantha; D G Fish
Journal:  Lepr Rev       Date:  1987-06       Impact factor: 0.537

4.  Cloning and expression of the Mycobacterium bovis BCG gene for extracellular alpha antigen.

Authors:  K Matsuo; R Yamaguchi; A Yamazaki; H Tasaka; T Yamada
Journal:  J Bacteriol       Date:  1988-09       Impact factor: 3.490

5.  The Mycobacterium leprae antigen 85 complex gene family: identification of the genes for the 85A, 85C, and related MPT51 proteins.

Authors:  T F Rinke de Wit; S Bekelie; A Osland; B Wieles; A A Janson; J E Thole
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

6.  Human T-cell clones recognize a major M. leprae protein antigen expressed in E. coli.

Authors:  A S Mustafa; H K Gill; A Nerland; W J Britton; V Mehra; B R Bloom; R A Young; T Godal
Journal:  Nature       Date:  1986 Jan 2-8       Impact factor: 49.962

7.  Characterization of fibronectin-binding antigens released by Mycobacterium tuberculosis and Mycobacterium bovis BCG.

Authors:  C Abou-Zeid; T L Ratliff; H G Wiker; M Harboe; J Bennedsen; G A Rook
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

8.  Purification, characterization and identification of a 32 kDa protein antigen of Mycobacterium bovis BCG.

Authors:  J De Bruyn; K Huygen; R Bosmans; M Fauville; R Lippens; J P Van Vooren; P Falmagne; M Weckx; H G Wiker; M Harboe
Journal:  Microb Pathog       Date:  1987-05       Impact factor: 3.738

9.  T-cell recognition of the 18-kilodalton antigen of Mycobacterium leprae.

Authors:  H M Dockrell; N G Stoker; S P Lee; M Jackson; K A Grant; N F Jouy; S B Lucas; R Hasan; R Hussain; K P McAdam
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441

10.  The recombinant 65-kD heat shock protein of Mycobacterium bovis Bacillus Calmette-Guerin/M. tuberculosis is a target molecule for CD4+ cytotoxic T lymphocytes that lyse human monocytes.

Authors:  T H Ottenhoff; B K Ab; J D Van Embden; J E Thole; R Kiessling
Journal:  J Exp Med       Date:  1988-11-01       Impact factor: 14.307

View more
  5 in total

1.  Enoyl-coenzyme A hydratase and antigen 85B of Mycobacterium habana are specifically recognized by antibodies in sera from leprosy patients.

Authors:  J Serafín-López; M Talavera-Paulin; J C Amador-Molina; M Alvarado-Riverón; M M Vilchis-Landeros; P Méndez-Ortega; M Fafutis-Morris; V Paredes-Cervantes; R López-Santiago; C I León; M I Guerrero; R M Ribas-Aparicio; G Mendoza-Hernández; C Carreño-Martínez; S Estrada-Parra; I Estrada-García
Journal:  Clin Vaccine Immunol       Date:  2011-05-25

2.  Lack of cytotoxic activity against Mycobacterium leprae 65-kD heat shock protein (hsp) in multibacillary leprosy patients.

Authors:  S de la Barrera; S Fink; M Finiasz; F Minnucci; R Valdez; L M Baliña; M C Sasiain
Journal:  Clin Exp Immunol       Date:  1995-01       Impact factor: 4.330

3.  Human T cell responses to peptides of the Mycobacterium leprae 45-kD serine-rich antigen.

Authors:  S Brahmbhatt; R Hussain; S Zafar; G Dawood; T H M Ottenhoff; J W Drijfhout; G Bothamley; S Smith; F V Lopez; H M Dockrell
Journal:  Clin Exp Immunol       Date:  2002-04       Impact factor: 4.330

4.  Use of a whole blood assay to evaluate in vitro T cell responses to new leprosy skin test antigens in leprosy patients and healthy subjects.

Authors:  R E Weir; P J Brennan; C R Butlin; H M Dockrell
Journal:  Clin Exp Immunol       Date:  1999-05       Impact factor: 4.330

5.  Fibronectin-binding antigen 85 and the 10-kilodalton GroES-related heat shock protein are the predominant TH-1 response inducers in leprosy contacts.

Authors:  P Launois; M N N'Diaye; J L Cartel; I Mane; A Drowart; J P Van Vooren; J L Sarthou; K Huygen
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.